PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-17

  1. 1,306 Posts.
    lightbulb Created with Sketch. 296
    Aaargh- fascinatin' it'll be indeed in 2-3 months......Voddy be drinking rum and we be dancing a gig!!!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.